Microwave ablation for recurrent primary hyperparathyroidism in four patients with multiple endocrine neoplasia type 1: a case series report

References

• Brandi ML, Agarwal SK, Perrier ND, et al. Multiple endocrine neoplasia type 1: latest insights. Endocr Rev. 2021;42(2):133–170. doi: 10.1210/endrev/bnaa031.
   PubMed Web of Science ®Google Scholar
• Mcdonnell JE, Gild ML, Clifton-Bligh RJ, et al. Multiple endocrine neoplasia: an update. Intern Med J. 2019;49(8):954–961. doi: 10.1111/imj.14394.
   PubMed Web of Science ®Google Scholar
• Allo M, Thompson NW, Harness JK, et al. Primary hyperparathyroidism in children, adolescents, and young adults. World J Surg. 1982;6(6):771–776. doi: 10.1007/BF01655371.
   PubMed Web of Science ®Google Scholar
• Thakker RV, Newey PJ, Walls GV, et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012;97(9):2990–3011. doi: 10.1210/jc.2012-1230.
   PubMed Web of Science ®Google Scholar
• Lamas C, Navarro E, Casterás A, et al. MEN1-associated primary hyperparathyroidism in the Spanish Registry: clinical characterictics and surgical outcomes. Endocr Connect. 2019;8(10):1416–1424. doi: 10.1530/EC-19-0321.
   PubMed Web of Science ®Google Scholar
• Waldmann J, López CL, Langer P, et al. Surgery for multiple endocrine neoplasia type 1-associated primary hyperparathyroidism. Br J Surg. 2010;97(10):1528–1534. doi: 10.1002/bjs.7154.
   PubMed Web of Science ®Google Scholar
• Thakker RV. Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4). Mol Cell Endocrinol. 2014;386(1–2):2–15. doi: 10.1016/j.mce.2013.08.002.
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhao Y, Han X, et al. Ultrasound-guided microwave ablation in the treatment of recurrent primary hyperparathyroidism in a patient with MEN1: a case report. Front Endocrinol. 2023;14:1175377. doi: 10.3389/fendo.2023.1175377.
   PubMed Web of Science ®Google Scholar
• Ni W, Yuan Y, Chu X, et al. Bone turnover markers in response to ultrasound-guided microwave ablation for primary hyperparathyroidism. Front Endocrinol. 2021;12:782050. doi: 10.3389/fendo.2021.782050.
   PubMed Web of Science ®Google Scholar
• Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 1997;276(5311):404–407. doi: 10.1126/science.276.5311.404.
   PubMed Web of Science ®Google Scholar
• Doherty GM. Multiple endocrine neoplasia type 1. J Surg Oncol. 2005;89(3):143–150. doi: 10.1002/jso.20181.
   PubMed Web of Science ®Google Scholar
• Nilubol N, Weinstein LS, Simonds WF, et al. Limited parathyroidectomy in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism: a setup for failure. Ann Surg Oncol. 2016;23(2):416–423. doi: 10.1245/s10434-015-4865-9.
   PubMed Web of Science ®Google Scholar
• Choi HR, Choi SH, Choi SM, et al. Benefit of diverse surgical approach on short-term outcomes of MEN1-related hyperparathyroidism. Sci Rep. 2020;10(1):10634. doi: 10.1038/s41598-020-67424-5.
   PubMed Web of Science ®Google Scholar
• Schreinemakers JMJ, Pieterman CRC, Scholten A, et al. The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review. World J Surg. 2011;35(9):1993–2005. doi: 10.1007/s00268-011-1068-9.
   PubMed Web of Science ®Google Scholar
• Bouriez D, Gronnier C, Haissaguerre M, et al. Less than subtotal parathyroidectomy for multiple endocrine neoplasia type 1 primary hyperparathyroidism: a systematic review and meta-analysis. World J Surg. 2022;46(11):2666–2675. doi: 10.1007/s00268-022-06633-7.
   PubMed Web of Science ®Google Scholar
• Pieterman CR, VAN Hulsteijn LT, DEN Heijer M, et al. Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype. Ann Surg. 2012;255(6):1171–1178. doi: 10.1097/SLA.0b013e31824c5145.
   PubMed Web of Science ®Google Scholar
• Fyrsten E, Norlén O, Hessman O, et al. Long-term surveillance of treated hyperparathyroidism for multiple endocrine neoplasia type 1: recurrence or hypoparathyroidism?. World J Surg. 2016;40(3):615–621. doi: 10.1007/s00268-015-3297-9.
   PubMed Web of Science ®Google Scholar
• Santucci N, Ksiazek E, Pattou F, et al. Recurrence after surgery for primary hyperparathyroidism in 517 patients with multiple endocrine neoplasia type 1. An AFCE and GTE study (Association Francophone de Chirurgie Endocrinienne and Groupe d‘etude des Tumeurs Endocrines). Ann Surg. 2023;279(2):340–345. doi: 10.1097/SLA.0000000000005980.
   Google Scholar
• Singh Ospina N, Thompson GB, Lee RA, et al. Safety and efficacy of percutaneous parathyroid ethanol ablation in patients with recurrent primary hyperparathyroidism and multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2015;100(1):E87–90. doi: 10.1210/jc.2014-3255.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update. Radiology. 2014;273(1):241–260. doi: 10.1148/radiol.14132958.
   PubMed Web of Science ®Google Scholar
• Zhang MZ, Gao YX, Zhang XJ, et al. Evaluation of efficacy of ultrasound-guided microwave ablation in primary hyperparathyroidism. J Clin Ultrasound. 2022;50(2):227–235. doi: 10.1002/jcu.23134.
   PubMed Web of Science ®Google Scholar
• Wu WJ, Zhou Q, Xu SH, et al. Two-year changes of biochemical profiles and bone mineral density after percutaneous ultrasound-guided microwave ablation for primary hyperparathyroidism. Endocrine. 2021;71(2):476–483. doi: 10.1007/s12020-020-02511-1.
   PubMed Web of Science ®Google Scholar
• Xu W, Li S, Cheng F, et al. Microwave ablation versus radiofrequency ablation for patients with primary and secondary hyperparathyroidism: a meta-analysis. Int Urol Nephrol. 2023;55(9):2237–2247. doi: 10.1007/s11255-023-03543-y.
   PubMed Web of Science ®Google Scholar
• Goldfarb M, Gondek S, Irvin GL, 3RD, et al. Normocalcemic parathormone elevation after successful parathyroidectomy: long-term analysis of parathormone variations over 10 years. Surgery. 2011;150(6):1076–1084. doi: 10.1016/j.surg.2011.09.017.
   PubMed Web of Science ®Google Scholar
• Carsello CB, Yen TW, Wang TS. Persistent elevation in serum parathyroid hormone levels in normocalcemic patients after parathyroidectomy: does it matter?. Surgery. 2012;152(4):575–583. discussion 81-3. doi: 10.1016/j.surg.2012.07.005.
   PubMed Web of Science ®Google Scholar
• Caldwell M, Laux J, Clark M, et al. Persistently elevated PTH after parathyroidectomy at one year: experience in a tertiary referral center. J Clin Endocrinol Metab. 2019;104(10):4473–4480. doi: 10.1210/jc.2019-00705.
   PubMed Web of Science ®Google Scholar